lamivudine and zidovudine
Generic: lamivudine and zidovudine
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
lamivudine and zidovudine
Generic Name
lamivudine and zidovudine
Labeler
bryant ranch prepack
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
lamivudine 150 mg/1, zidovudine 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71335-0639
Product ID
71335-0639_aa348cf2-2e1b-486f-9bec-5ccf67879175
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA079124
Listing Expiration
2026-12-31
Marketing Start
2015-09-18
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
713350639
Hyphenated Format
71335-0639
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lamivudine and zidovudine (source: ndc)
Generic Name
lamivudine and zidovudine (source: ndc)
Application Number
ANDA079124 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
- 300 mg/1
Packaging
- 6 TABLET, FILM COATED in 1 BOTTLE (71335-0639-1)
- 60 TABLET, FILM COATED in 1 BOTTLE (71335-0639-2)
- 4 TABLET, FILM COATED in 1 BOTTLE (71335-0639-3)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "aa348cf2-2e1b-486f-9bec-5ccf67879175", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95", "4B9XT59T7S"], "rxcui": ["200082"], "spl_set_id": ["005f1b9d-1950-4ef3-a9d6-c428a40a3630"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "6 TABLET, FILM COATED in 1 BOTTLE (71335-0639-1)", "package_ndc": "71335-0639-1", "marketing_start_date": "20210402"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (71335-0639-2)", "package_ndc": "71335-0639-2", "marketing_start_date": "20211227"}, {"sample": false, "description": "4 TABLET, FILM COATED in 1 BOTTLE (71335-0639-3)", "package_ndc": "71335-0639-3", "marketing_start_date": "20211227"}], "brand_name": "LAMIVUDINE and ZIDOVUDINE", "product_id": "71335-0639_aa348cf2-2e1b-486f-9bec-5ccf67879175", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "71335-0639", "generic_name": "LAMIVUDINE and ZIDOVUDINE", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LAMIVUDINE and ZIDOVUDINE", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}, {"name": "ZIDOVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA079124", "marketing_category": "ANDA", "marketing_start_date": "20150918", "listing_expiration_date": "20261231"}